Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparing Antipsychotic Medications in LBD Over Time
Sponsor: The University of Texas Health Science Center at San Antonio
Summary
The primary objective of this study is to determine whether treatment with pimavanserin or quetiapine is associated with a greater improvement in psychosis when used in a routine clinical setting to treat hallucinations and/or delusions due to Parkinson's disease (PD) or dementia with Lewy bodies (DLB) - collectively referred to as Lewy body disease (LBD).
Official title: A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body Disease
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
94
Start Date
2022-04-22
Completion Date
2027-02
Last Updated
2025-09-09
Healthy Volunteers
No
Interventions
Pimavanserin
Dosage choice and further medication management will be at the discretion of the treating clinician, per routine clinical practice.
Quetiapine
Dosage choice and further medication management will be at the discretion of the treating clinician, per routine clinical practice.
Locations (2)
University Health System
San Antonio, Texas, United States
UT Health Science Center - San Antonio
San Antonio, Texas, United States